Enantioselective syntheses of georgyone, arborone, and structural relatives. Relevance to the molecular-level understanding of olfaction

Journal of the American Chemical Society

Volumn 128, Issue 4, 2006, Pages 1346-1352

  Hong, Sungwoo ^a   Corey, E J ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHANOL; MOLECULAR DYNAMICS; MOLECULAR STRUCTURE; ODORS; PROTEINS; SYNTHESIS (CHEMICAL);

ENANTIOMERS; ENANTIOSELECTIVE SYNTHESES; G-PROTEIN-COUPLED RECEPTORS; STRUCTURAL REQUIREMENTS;

KETONES;

ARBORONE; GEORGYONE; GUANINE NUCLEOTIDE BINDING PROTEIN; ORGANIC COMPOUND; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHIRALITY; DIELS ALDER REACTION; ENANTIOMER; ENANTIOSELECTIVITY; LIGAND BINDING; ODOR; OLFACTORY RECEPTOR; OXIDATION; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; CYCLIZATION; CYCLOHEXANES; KETONES; MICE; MODELS, MOLECULAR; NAPHTHALENES; ODORS; RECEPTORS, ODORANT; STEREOISOMERISM;

EID: 31944433641     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja057483x     Document Type: Article

References (60)

1. (a) Axel, R. Nobel Lecture in Physiology and Medicine for 2004. Angew. Chem., Int. Ed. 2005, 44, 6111-6127.
2. (b) Buck, L. B. Nobel Lecture in Physiology and Medicine for 2004. Angew. Chem., Int. Ed. 2005, 44, 6128-6140 and www.nobel.se.
3. (c) Buck, L. B. Annu. Rev. Neurosci. 1996, 19, 517-544.
4. (a) Buck, L. B.; Axel, R. Cell 1991, 65, 175-187.
5. (b) Malnic, B.; Godfrey, P. A.; Buck, L. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 2584-2589.
6. (c) Godfrey, P. A.; Malnic, B.; Buck, L. B. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 2156-2161.
7. (d) Malnic, B.; Hirono, J.; Sato, T.; Buck, L. B. Cell 1999, 96, 713-723.
8. (e) Buck, L. B. Cell 2000, 100, 611-618.
9. (f) Takahashi, Y. K.; Kurosaki, M.; Hirono, S.; Mori, K. J. Neurophysiol. 2004, 92, 2413-2427.
10. (g) Uchida, N.; Takahashi, Y. K.; Tanifuji, M.; Mori, K. Nature Neurosci. 2000, 3, 1035-1043.
11. (h) Ronnett, G. V.; Moon, C. Annu. Rev. Physiol. 2002, 64, 189-222.
12. (i) Vosshall, L. B. Curr. Opin. Neurobiol. 2000, 10, 498-503.
13. Glusman, G.; Yanai, I.; Lancet, D. Genome Res. 2001, 11, 685-702 (the complete human olfactory subgenome).
14. Serizawa, S.; Miyamichi, K.; Nakatani, H.; Suzuki, M.; Saito, M.; Yoshihara, Y.; Sakano, H. Science 2003, 302, 2088-2091 (regulation of OR gene expression).
15. (a) Pybus, D. H.; Sell, C. S. The Chemistry of Odors; RSC Paperbacks, Royal Society of Chemistry: London, 1999.
16. (b) Kraft, P.; Bajgrowicz, J. A.; Denis, C.; Fráter, G. Angew. Chem., Int. Ed. 2000, 39, 2980-3010; see also http://www.iff.com/Ingredients. nsf.
17. (c) Brenna, E.; Fuganti, C.; Serra, S. Tetrahedron: Asymmetry 2003, 14, 1-42.
18. We are indebted to Dr. G. Fráter of Givaudan Dübendorf AG for a gift of racemic Georgywood.
19. Fráter, G.; Bajgrowicz, J. A.; Kraft, P. Tetrahedron 1998, 54, 7633-7703.
20. Nussbaumer, C.; Fráter, G.; Kraft, P. Helv. Chim. Acta 1999, 82, 1016-1024.
21. (a) Corey, E. J.; Shibata, T.; Lee, T. W. J. Am. Chem. Soc. 2002, 124, 3808-3809.
22. (b) Ryu, D. H.; Lee, T. W.; Corey, E. J. J. Am. Chem. Soc. 2002, 124, 9992-9993.
23. (c) Ryu, D. H.; Corey, E. J. J. Am. Chem. Soc. 2003, 125, 6388-6390.
24. (d) Zhou, G.; Hu, Q.-Y.; Corey, E. J. Org. Lett. 2003, 5, 3979-3982.
25. (e) Ryu, D. H.; Zhou, G.; Corey, E. J. J. Am. Chem. Soc. 2004, 126, 4800-4802.
26. (f) Hu, Q.-Y.; Rege, P. D.; Corey, E. J. J. Am. Chem. Soc. 2004, 126, 5984-5986.
27. (g) Hu, Q.-Y.; Zhou, G.; Corey, E. J. J. Am. Chem. Soc. 2004, 126, 13708-13713.
28. Although synthetic 1 was contaminated by about 10% of the (1S,2S)-diastereomer, there is no contribution of this impurity to odor since it is essentially odorless, as shown in a later section of this paper.
29. Odor testing was carried out with several members of our research group, including the authors, with good agreement on the consensus evaluation of odor.
30. See: Fráter, G.; Müller, U.; Schröder, F. Tetrahedron: Asymmetry 2004, 15, 3967-3972.
31. Dragoli, D. R.; Burdett, M. T.; Ellman, J. A. J. Am. Chem. Soc. 2001, 123, 10127-10128.
32. Corey, E. J.; Boaz, N. W. Tetrahedron Lett. 1985, 26, 6019-6022.
33. Kabalka, G. W.; Yang, D. T. C.; Baker, J. D. J. Org. Chem. 1976, 41, 574-575.
34. Spectral data for (+)-(2) were in agreement with those reported for the racemate: Fráter, G.; Kraft, P. Helv. Chim. Acta 1999, 82, 1016.
35. 2O. For precedent, see: Kavanobe, T.; Kogami, K.; Hayashi, K.; Matsui, M. Agric. Biol. Chem. 1984, 48, 461-464.
36. The Diels-Alder reaction can be carried out using an excess of the racemic diene 17 because of a faster rate of reaction for the (R)- vs the (S)-enantiomer, an interesting illustration of the efficacy of catalyst 5. This is an unusual example of kinetic resolution in a catalytic enantioselective Diels-Alder reaction.
37. For the synthetic procedure for pulegone → enone 21. see: Caine, D.; Procter, K.; Casall, R. A. J. Org. Chem. 1984, 49, 2647-2648.
38. Mi, Y.; Schreiber, J. J.; Corey, E. J. J. Am. Chem. Soc. 2002, 124, 11290-11291.
39. The results that are summarized in Scheme 7 also show that this particular Diels-Alder reaction is not useful for the synthesis of (+)-2, although we entertained this possibility when considering alternative synthetic routes to 2 that are simpler than the one set out in Scheme 2.
40. For details of X-ray diffraction analysis of the tosylhydrazone of 38, see the Supporting Information.
41. (a) Takeuchi, H.; Kurahashi, T. J. Gen. Physiol. 2003, 122, 557-567.
42. (b) Barry, P. H. J. Gen. Physiol. 2003, 122, 247-250.
43. (c) Madrid, R.; Delgado, R.; Bacigalupo, J. J. Neurophysiol. 2005, 94, 1781-1788.
44. For a summary of older work on the possibility of multiple second messengers, see: Schild, D.; Restrepo, D. Physiol. Rev. 1998, 78, 429-466.
45. (a) Uchida, N.; Takahashi, Y. K.; Tanifuji, M.; Mori, K. Nature Neurosci. 2000, 3, 1035-1043.
46. (b) Takahasi, Y. K.; Kurosaki, M.; Hirono, S.; Mori, K. J. Neurophysiol. 2004, 92, 2413-2427.
47. (c) Araneda, R. C.; Kini, A. D.; Firestein, S. Nature Neurosci. 2000, 3, 1248-1255.
48. This collaborative research by the authors. Prof. Meister and Mr. Edward Soucy, will be described in detail elsewhere.
49. Bozza, T.; McGann, J. P.; Mombaerts, P.; Wachowiak, M. Neuron 2004, 42, 9-21.
50. Only about 20% of the mouse olfactory glomeruli are accessible for study using the optical analysis technique. It is thus possible that additional glomeruli are activated by olfactory ligands 1 and 2.
51. (a) Fredriksson, R.; Lagerström, M. C.; Lundin, L.-G.; Schiöth, H. B. Mol. Pharmacol. 2003, 63, 1256-1272.
52. (b) Ballesteros, J. A.; Shi, L.; Javitch, J. A. Mol. Pharmacol. 2001, 60, 1-19.
53. (c) Ballesteros, J. A.; Palczewski, K. Curr. Opin. Drug Discovery Dev. 2001, 4, 561-574.
54. (d) Mirzadegan, T.; Benkö, G.; Filipek, S.; Palczewski, K. Biochemistry 2003, 42, 2759-2767.
55. Katada, S.; Hirokawa, T.; Oka, Y.; Suwa, M.; Touhara, K. J. Neurosci. 2005, 25, 1806-1815.
56. For other interesting recent studies on ligand binding to ORs with simple compounds (e.g. 1-hexanol), see: (a) Floriano, W. B.; Vaidehi, N.; Goddard, W. A., III; Singer, M. S.; Shepherd, G. M. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 10712-10716.
57. (b) Frimurer, T. M.; Ulven, T.; Elling, C. E.; Gerlach, L.-O.; Kostenis, E.; Högberg, T. Bioorg. Med. Chem. Lett. 2005, 15, 3707-3712.
58. (c) Man, O.; Gilad, Y.; Lancet, D. Protein Sci. 2004, 13, 240-254.
59. Berger, J.; Moller, D. E. Annu. Rev. Med. 2002, 53, 409-435.
60. Kenakin, T. Trends Phamacol. Sci. 1996, 17, 190-191.